JPRN-UMIN000017081已完成未知
Comparison of intravitreal ranibizumab injection with or without tissue plasminogen activator in the treatment of type 2 choroidal neovascularization - Effect of tissue plasminogen activator on type 2 choroidal neovascularization
Department of Ophthalmology and Visual Science Nagoya City University Graduate School of Medical Sciences0 个研究点目标入组 20 人开始时间: 2015年4月10日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional,observational
入排标准
- 年龄范围
- 50years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •previous treatments involving laser photocoagulation or photodynamic therapy
研究者
相似试验
进行中（未招募）
不适用
Comparison of the effect of intravitreal ranibizumab injections compared to macular grid-pattern laser therapy for the symptomatic treatment of diabetic macular edema (a randomized, controlled, phase III trial)Randomizált, kontrollált, III. fázisú klinikai vizsgálat az intravitreális ranibizumab injekció és a makula „grid pattern” (rács mintázatú) lézerkezelés hatásának összehasonlítására a diabéteszes makula ödéma tüneti kezelésében.Diabetic Macular EdemaMedDRA version: 9.1Level: LLTClassification code 10057934Term: Diabetic macular edemaEUCTR2008-007232-18-HUniversity of Szeged, Medical and Pharmaceutical Center, Department of Ophthalmology50
尚未招募
4 期
Prospective study of Intravitreal Ranibizumab for Exudative Age-Related Macular Degeneration in Japanese PatientsExudative Age-Related Macular DegenerationJPRN-UMIN000027799Akita University Department of Ophthalmology50
已完成
不适用
Comparison of inravitreal ranibizumab therapy with and without laser photocoagulation for diabetic macular edema.diabetic macular edemaJPRN-UMIN000024697Tokyo Women's Medical University100
招募中
不适用
The effect of intravitreal ranibizumab on systemic hypertension in age-related macular degeneration patients with hypertension.age-related macular degenerationJPRN-UMIN000013240Institute of Health Biosciences, The University of Tokushima Graduate School80
已完成
4 期
A multicentre,open-label,prospective,observational study to evaluate effectiveness and safety of repeated intravitreal injections of Lucentis® in patients with wet age-related macular degeneration over a 12-month observational period in a real-world settingCTRI/2013/08/003933ovartis India Limited3,000